MAFLD: Renovation of clinical practice and disease awareness of fatty liver

• Published in: Hepatology research Vol. 52; no. 5; pp. 422 - 432
• Main Authors: Kawaguchi, Takumi, Tsutsumi, Tsubasa, Nakano, Dan, Torimura, Takuji
• Format: Journal Article
• Language: English
• Published: Netherlands Wiley Subscription Services, Inc 01.05.2022
• Subjects: Atherosclerosis; atherosclerotic cardiovascular disease; Clinical medicine; Clinical trials; disease awareness; Fatty liver; hepatic fibrosis; Liver diseases; metabolic‐associated fatty liver; Metabolism; Risk factors; steatosis; metabolic-associated fatty liver; atherosclerotic cardiovascular disease; disease awareness; hepatic fibrosis; steatosis

Recently, international expert panels have proposed a new definition of fatty liver: metabolic dysfunction‐associated fatty liver disease (MAFLD). MAFLD is not just a simple renaming of non‐alcoholic fatty liver disease (NAFLD). The unique feature of MAFLD is the inclusion of metabolic dysfunctions,...